Increased expression and activity of 11β-HSD-1 in diabetic islets and prevention with troglitazone

Laurence Duplomb, Young H Lee, May-Yun Wang, Byung H. Park, Kiyosumi Takaishi, Anil K Agarwal, Roger H Unger

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

To determine if increased local production of glucocorticoids by the pancreatic islets might play a role in the spontaneous noninsulin-dependent diabetes mellitus of obesity, we compared islet 11β-HSD-1 mRNA and activity in islets of obese prediabetic and diabetic Zucker Diabetic Fatty (ZDF) (fa/fa) rats and lean wild-type (+/+) controls. In diabetic rat islets, both mRNA and enzymatic activity of the enzyme were increased in proportion to the hyperglycemia. Troglitazone (TGZ) treatment, beginning at 6 weeks of age, prevented the hyperglycemia, the hyperlipidemia, and the increase in 11β-HSD-1. To determine if the metabolic abnormalities had caused the 11β-HSD-1 increase, prediabetic islets were cultured in high or low glucose or in 2:1 oleate:palmitate for 3 days. Neither nutrient enhanced the expression of 11β-HSD-1. We conclude that 11β-HSD-1 expression and activity are increased in islets of diabetic, but not prediabetic ZDF rats, and that TGZ prevents both the increase in 11β-HSD-1 and the diabetes.

Original languageEnglish (US)
Pages (from-to)594-599
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume313
Issue number3
DOIs
StatePublished - Jan 16 2004

Fingerprint

troglitazone
Rats
Medical problems
Hyperglycemia
Messenger RNA
Palmitates
Oleic Acid
Hyperlipidemias
Islets of Langerhans
Type 2 Diabetes Mellitus
Glucocorticoids
Nutrients
Obesity
Glucose
Food
Enzymes

Keywords

  • 11β-HSD-1
  • Cushing's syndrome and obesity
  • Glucocorticoid
  • Islets
  • ZDF (fa/fa) rats

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Increased expression and activity of 11β-HSD-1 in diabetic islets and prevention with troglitazone. / Duplomb, Laurence; Lee, Young H; Wang, May-Yun; Park, Byung H.; Takaishi, Kiyosumi; Agarwal, Anil K; Unger, Roger H.

In: Biochemical and Biophysical Research Communications, Vol. 313, No. 3, 16.01.2004, p. 594-599.

Research output: Contribution to journalArticle

@article{2818fffac8b446949863a2a472295eeb,
title = "Increased expression and activity of 11β-HSD-1 in diabetic islets and prevention with troglitazone",
abstract = "To determine if increased local production of glucocorticoids by the pancreatic islets might play a role in the spontaneous noninsulin-dependent diabetes mellitus of obesity, we compared islet 11β-HSD-1 mRNA and activity in islets of obese prediabetic and diabetic Zucker Diabetic Fatty (ZDF) (fa/fa) rats and lean wild-type (+/+) controls. In diabetic rat islets, both mRNA and enzymatic activity of the enzyme were increased in proportion to the hyperglycemia. Troglitazone (TGZ) treatment, beginning at 6 weeks of age, prevented the hyperglycemia, the hyperlipidemia, and the increase in 11β-HSD-1. To determine if the metabolic abnormalities had caused the 11β-HSD-1 increase, prediabetic islets were cultured in high or low glucose or in 2:1 oleate:palmitate for 3 days. Neither nutrient enhanced the expression of 11β-HSD-1. We conclude that 11β-HSD-1 expression and activity are increased in islets of diabetic, but not prediabetic ZDF rats, and that TGZ prevents both the increase in 11β-HSD-1 and the diabetes.",
keywords = "11β-HSD-1, Cushing's syndrome and obesity, Glucocorticoid, Islets, ZDF (fa/fa) rats",
author = "Laurence Duplomb and Lee, {Young H} and May-Yun Wang and Park, {Byung H.} and Kiyosumi Takaishi and Agarwal, {Anil K} and Unger, {Roger H}",
year = "2004",
month = "1",
day = "16",
doi = "10.1016/j.bbrc.2003.11.160",
language = "English (US)",
volume = "313",
pages = "594--599",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Increased expression and activity of 11β-HSD-1 in diabetic islets and prevention with troglitazone

AU - Duplomb, Laurence

AU - Lee, Young H

AU - Wang, May-Yun

AU - Park, Byung H.

AU - Takaishi, Kiyosumi

AU - Agarwal, Anil K

AU - Unger, Roger H

PY - 2004/1/16

Y1 - 2004/1/16

N2 - To determine if increased local production of glucocorticoids by the pancreatic islets might play a role in the spontaneous noninsulin-dependent diabetes mellitus of obesity, we compared islet 11β-HSD-1 mRNA and activity in islets of obese prediabetic and diabetic Zucker Diabetic Fatty (ZDF) (fa/fa) rats and lean wild-type (+/+) controls. In diabetic rat islets, both mRNA and enzymatic activity of the enzyme were increased in proportion to the hyperglycemia. Troglitazone (TGZ) treatment, beginning at 6 weeks of age, prevented the hyperglycemia, the hyperlipidemia, and the increase in 11β-HSD-1. To determine if the metabolic abnormalities had caused the 11β-HSD-1 increase, prediabetic islets were cultured in high or low glucose or in 2:1 oleate:palmitate for 3 days. Neither nutrient enhanced the expression of 11β-HSD-1. We conclude that 11β-HSD-1 expression and activity are increased in islets of diabetic, but not prediabetic ZDF rats, and that TGZ prevents both the increase in 11β-HSD-1 and the diabetes.

AB - To determine if increased local production of glucocorticoids by the pancreatic islets might play a role in the spontaneous noninsulin-dependent diabetes mellitus of obesity, we compared islet 11β-HSD-1 mRNA and activity in islets of obese prediabetic and diabetic Zucker Diabetic Fatty (ZDF) (fa/fa) rats and lean wild-type (+/+) controls. In diabetic rat islets, both mRNA and enzymatic activity of the enzyme were increased in proportion to the hyperglycemia. Troglitazone (TGZ) treatment, beginning at 6 weeks of age, prevented the hyperglycemia, the hyperlipidemia, and the increase in 11β-HSD-1. To determine if the metabolic abnormalities had caused the 11β-HSD-1 increase, prediabetic islets were cultured in high or low glucose or in 2:1 oleate:palmitate for 3 days. Neither nutrient enhanced the expression of 11β-HSD-1. We conclude that 11β-HSD-1 expression and activity are increased in islets of diabetic, but not prediabetic ZDF rats, and that TGZ prevents both the increase in 11β-HSD-1 and the diabetes.

KW - 11β-HSD-1

KW - Cushing's syndrome and obesity

KW - Glucocorticoid

KW - Islets

KW - ZDF (fa/fa) rats

UR - http://www.scopus.com/inward/record.url?scp=0347064002&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0347064002&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2003.11.160

DO - 10.1016/j.bbrc.2003.11.160

M3 - Article

C2 - 14697232

AN - SCOPUS:0347064002

VL - 313

SP - 594

EP - 599

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 3

ER -